NIH Director Jay Bhattacharya offered an explanation for the cancellation of mRNA vaccine contracts that didn't align with ...

In litigation over the past two years, CureVac alleged the BioNTech and Pfizer vaccine for Covid-19 infringed CureVac patents ...

Researchers have launched HTGAnalyzer, a new, easy-to-use, fast and reproducible bioinformatics tool for advanced ...

"People are going to die because we're cutting short funding for this technology," Dr. Jerome Adams said in an interview with CBS News on Aug. 10.

Market opportunities for mRNA synthesis raw materials lie in the growing demand for high-purity materials driven by mRNA therapeutics. Key drivers include advancements in mRNA technology, regulatory ...

The Department of Health and Human Services announced Thursday that it will cut nearly half a billion dollars in funding for 22 vaccine development programs, many of which ...

THESE WERE JUST THREE of the specious claims Kennedy made; there were others, too. But it’s likely that for many people who ...

CDC employees across all of the agency’s campuses will be teleworking today, after a gunman shot multiple rounds into four ...

CureVac ( (CVAC)) has provided an announcement. On August 7, 2025, CureVac announced the resolution of U.S. patent litigation with Pfizer/BioNTech concerning mRNA-based COVID-19 vaccines. As part of ...

Rapid spending isn’t always a sign of progress. Some cash-burning businesses fail to convert investments into meaningful ...

HHS Secretary Robert F Kennedy Jr has canceled nearly $500 million in grants and contracts meant to support mRNA vaccine development.

Company to Webcast Investor Event on August 30, 2025, at 1:00 p.m. EDT (7:00 pm CEST)- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced that ...